STOCK TITAN

AORT ownership update: BlackRock now holds nearly 6M shares, 13.9% of float

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

BlackRock, Inc. has filed Amendment No. 4 to Schedule 13G revealing a 5,950,909-share position in Artivion, Inc. (AORT) as of 30 June 2025. The stake equals 13.9 % of the outstanding common stock, giving BlackRock sole voting authority over 5,884,199 shares and sole dispositive authority over all 5,950,909 shares; no shared authority is reported.

The disclosure is made pursuant to Rule 13d-1(b) with BlackRock classified as a parent holding company/control person (HC). Management certifies the shares are held in the ordinary course, without intent to influence control. The filing notes that the iShares Core S&P Small-Cap ETF, a BlackRock vehicle, independently owns more than 5 % of Artivion’s float.

A double-digit passive stake from the world’s largest asset manager enhances Artivion’s institutional ownership base and may support liquidity, but the absence of activist language suggests no immediate strategic impact.

Positive

  • BlackRock holds 13.9 % of Artivion’s common stock, indicating strong institutional support and enhanced liquidity.

Negative

  • Concentration risk: a large passive stake could create selling pressure if ETF mandates shift or rebalance.

Insights

TL;DR: 13.9 % passive stake shows confidence but no control ambitions.

BlackRock’s nearly 6 million-share holding firmly places Artivion within major ETF and index-fund mandates, likely stabilising trading volumes and widening the investor base. As the filing is a 13G (not 13D), it signals passive intent, so governance intervention is unlikely. For AORT shareholders, the disclosure is neutral-to-positive: higher institutional sponsorship can lower volatility, yet the same stake could become an overhang should ETF rebalancing trigger sales. Absent evidence of buying or selling trends versus prior amendments, the market impact should be modest.

TL;DR: Large passive ownership boosts oversight optics, limited strategic implications.

BlackRock’s 13.9 % ownership increases the free-float portion held by a governance-focused institution, which often presses boards on ESG and compensation through proxy voting. However, because voting authority is exercised across multiple index products, influence is diffuse. The filing’s certification that the shares are not for control purposes confirms no takeover risk. Overall governance risk profile remains unchanged; disclosure is impactful only in signalling continued institutional monitoring.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



BlackRock, Inc.
Signature:Spencer Fleming
Name/Title:Managing Director
Date:07/21/2025
Exhibit Information

Exhibit 24: Power of Attorney Exhibit 99: Item 7

Artivion, Inc.

NYSE:AORT

AORT Rankings

AORT Latest News

AORT Latest SEC Filings

AORT Stock Data

1.69B
43.79M
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
KENNESAW